SoT,
So we should expect a license from Roche, Pfizer and/or Janssen this year?? Or at least Pfizer or Janssen, since they are "close"? Is that the info you get from Mgmt and were able to confirm with major shareholders?
I am all for "evolving/optimizing/improving" the libraries/discovery platform. When does that translate into a sustainable business plan? Q4? Next year? or is that not so important?
Also, not to be critical, but they are not identifying "cell-specific peptides that can penetrate cell membranes" as you wrote, they are identifying peptides that bind to cell-specific receptors and carry a cargo into cells because these receptors recycle into cells from the membrane. They believe they have a better way to release these cargos from this recycling (endosomal/vesicle pathway) process into the cytoplasm where most of the targets exist. That is the basic concept for their screening method. And the concept is not new.
- Forums
- ASX - By Stock
- Ann: Shareholder Update
SoT,So we should expect a license from Roche, Pfizer and/or...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $466.6M |
Open | High | Low | Value | Volume |
10.0¢ | 10.3¢ | 9.9¢ | $212.5K | 2.127M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 711139 | 9.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 914653 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 711139 | 0.099 |
2 | 60000 | 0.098 |
4 | 210376 | 0.097 |
1 | 100000 | 0.096 |
2 | 72500 | 0.095 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 914653 | 9 |
0.110 | 808292 | 5 |
0.115 | 1298747 | 6 |
0.120 | 570289 | 4 |
0.125 | 366111 | 3 |
Last trade - 16.10pm 08/08/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |